Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Recursion Pharmaceuticals Inc Cl A 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 USA

www.recursion.com Employees: 800 P: 385-269-0203

Sector:

Medical

Description:

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

Key Statistics

Overview:

Market Capitalization, $K 2,146,931
Enterprise Value, $K 1,568,551
Shares Outstanding, K 519,838
Annual Sales, $ 58,840 K
Annual Net Income, $ -463,660 K
Last Quarter Sales, $ 5,180 K
Last Quarter Net Income, $ -162,250 K
EBIT, $ -723,570 K
EBITDA, $ -687,080 K
60-Month Beta 0.94
% of Insider Shareholders 8.43%
% of Institutional Shareholders 89.06%
Float, K 476,016
% Float 91.57%
Short Interest 153,739
Short Float 29.57%
Short Volume Ratio 0.40

Growth:

1-Year Return -44.11%
3-Year Return -44.49%
5-Year Return 0.00%
5-Year Revenue Growth 2,436.21%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.36 on 11/05/25
Next Earnings Date 02/27/26
Earnings Per Share ttm -1.80
EPS Growth vs. Prev Qtr 12.20%
EPS Growth vs. Prev Year -5.88%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RXRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -72.74%
Return-on-Assets % -52.46%
Profit Margin % -788.00%
Debt/Equity 0.01
Price/Sales 37.55
Price/Cash Flow N/A
Price/Book 2.07
Book Value/Share 2.13
Interest Coverage -1.61
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar